Ligand validation:2VLX

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VLX_GOL_A_1159	55%	86%	0.126	0.895	0.41	0.32	-	-	0	0	100%	0.5
2VLX_GOL_A_1158	8%	88%	0.143	0.608	0.39	0.29	-	-	1	0	100%	1
2V1G_GOL_A_1158	74%	76%	0.099	0.929	0.39	0.56	-	-	0	0	100%	1
5AZR_GOL_A_1006	74%	37%	0.108	0.938	0.83	1.6	-	2	0	0	100%	0.5
2V1H_GOL_A_1158	60%	90%	0.152	0.936	0.34	0.26	-	-	1	0	100%	1
3WFT_GOL_A_1006	53%	65%	0.145	0.905	0.73	0.63	-	-	2	0	100%	0.5
2V1E_GOL_A_1158	49%	82%	0.16	0.906	0.41	0.39	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.